Tardive dyskinesia usually occurs late in neuroleptic treatment and often appears only when neuroleptic medication is discontinued. As opposed to the other three extrapyramidal side-effects, tardive dyskinesia is relatively refractory to treatment and is often considered an untreatable, permanent side-effect of neuroleptic medications. The following case report illustrates many of the problems associated with the management of tardive dyskinesia. A pharmacological model is discussed.
|Original language||English (US)|
|Number of pages||6|
|Journal||Johns Hopkins Medical Journal|
|State||Published - Jan 1 1981|
ASJC Scopus subject areas